Vascular dysfunction in women with recurrent pregnancy loss: Possible association with antiphospholipid antibodies
International Journal of Gynecology & Obstetrics · 2025
DOI: 10.1002/ijgo.16051 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Titi Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan. Hauptthemen laut MEDLINE: Abortion, Habitual, Antibodies, Antiphospholipid, Vascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Agenția Națională pentru Cercetare și Dezvoltare.
Abstract (Originalsprache)
Objective
Antiphospholipid antibodies (aPL) are recognized to have a pivotal role in recurrent pregnancy loss (RPL) and cardiovascular disease. Therefore, we assessed the vascular function of women with RPL and examined the association with each type of aPL.
Methods
In this retrospective study, 569 women with RPL and 55 healthy women who had never experienced pregnancy loss were recruited. We performed blood tests for aPL and acceleration plethysmography (APG) to evaluate peripheral vascular function.
Results
The differential pulse wave index (DPI), indicating vascular elasticity, was significantly lower in women with RPL (115.6 ± 4.1) compared to the control group (117.0 ± 2.3). DPI in RPL women with anti‐β 2 glycoprotein I (aβ 2 GPI) IgG was significantly lower than those without. Remained blood volume (RBV), indicating post‐vasoconstriction blood content, was significantly higher in RPL women with aβ 2 GI IgG than in those without. Regression analysis showed aβ 2 GPI IgG and body mass index (BMI) linked negatively with DPI.
Conclusion
Women with RPL have subclinical vascular dysfunction even at reproductive age. It is possible that aβ 2 GPI IgG is associated with vascular dysfunction in RPL women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
- Graduate School of Health Sciences, Okayama University, Okayama, Japan.
- Reproduction Center, Okayama University Hospital, Okayama, Japan.
- Faculty of Health Sciences, Okayama University, Okayama, Japan.
- Department of Obstetrics and Gynecology, Okayama University Hospital, Okayama, Japan.
ORCID-Profile: Titi Yang, Mikiya Nakatsuka
Förderung
- Agenția Națională pentru Cercetare și Dezvoltare
Zitieren
APA
Yang, T., Okada, E., Todoroki, M., Liu, S., Athurupana, R., Kataoka, K., Kashino, C., Mitsui, T., Hasegawa, T., Kamada, Y., Masuyama, H., & Nakatsuka, M. (2025). Vascular dysfunction in women with recurrent pregnancy loss: Possible association with antiphospholipid antibodies. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.16051
Vancouver
Yang T, Okada E, Todoroki M, Liu S, Athurupana R, Kataoka K, et al. Vascular dysfunction in women with recurrent pregnancy loss: Possible association with antiphospholipid antibodies. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.16051
BibTeX
@article{Yang2025,
author = {Yang, Titi and Okada, Emi and Todoroki, Maho and Liu, Siyu and Athurupana, Rukmali and Kataoka, Kumie and Kashino, Chiaki and Mitsui, Takashi and Hasegawa, Toru and Kamada, Yasuhiko and Masuyama, Hisashi and Nakatsuka, Mikiya},
title = {Vascular dysfunction in women with recurrent pregnancy loss: Possible association with antiphospholipid antibodies},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
doi = {10.1002/ijgo.16051}
}
EUVIMED